Deena Masciocchi
Psychiatric/Mental Health · Langhorne, PANPI 1366798431
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $64,900 of the $70,611 with a category attached, or 91.9%. AbbVie accounts for 94.4% of it on its own, with 25 other manufacturers making up the rest. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $189.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$67K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$758
- Johnson & Johnson$385
- Axsome Therapeutics, Inc.$372
- Lundbeck LLC$370
- Otsuka America Pharmaceutical, Inc.$341
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$64,90092%
- Food & beverage$5,5538%
- Education$1580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 167 | $66,629 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $758 |
| Johnson & Johnson | 12 | $385 |
| Axsome Therapeutics, Inc. | 18 | $372 |
| Lundbeck LLC | 21 | $370 |
| Otsuka America Pharmaceutical, Inc. | 22 | $341 |
| Vanda Pharmaceuticals Inc. | 17 | $303 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $227 |
| Corium, LLC | 13 | $205 |
| Neos Therapeutics, LP | 10 | $172 |
| Ironshore Pharmaceuticals Inc. | 7 | $167 |
| Tris Pharma Inc | 6 | $133 |
| Collegium Pharmaceutical, Inc. | 7 | $128 |
| Neurocrine Biosciences, Inc. | 4 | $75 |
| Alkermes, Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 3 | $46 |
| Novo Nordisk | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $29 |
| Bioxcel Therapeutics, Inc. | 1 | $26 |
| Pfizer | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Braeburn Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,611 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 14 | $5,680 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $892 |
| Mirtazapine | 20 | $611 |
| Bupropion XlBupropion Hcl | 14 | $482 |
| Fluoxetine Hcl | 55 | $378 |
| Alprazolam | 45 | $260 |
| Quetiapine Fumarate | 22 | $243 |
| Paroxetine Hcl | 12 | $232 |
| Gabapentin | 17 | $211 |
| Clonazepam | 25 | $202 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $197 |
| Escitalopram Oxalate | 15 | $125 |
| Zolpidem Tartrate | 16 | $108 |
| Lorazepam | 21 | $67 |
| Lamotrigine | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Langhorne
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
- Dylan KilmerGreenfield Township$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.